Analysis of the cases with haemoptysis in hospitalized patients (3 years retrospective study) Source: Eur Respir J 2001; 18: Suppl. 33, 379s Year: 2001
Are SABA-reliant asthma patients receiving adequate ICS therapy? A nationwide cohort study in Sweden (HERA) Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies Year: 2019
Pneumocystis jirovecii (PCP) in non-HIV infected patients: A retrospective study on 41 cases between 1999 and 2009Source: Annual Congress 2010 - Unusual pathogens in respiratory infections Year: 2010
Tocilizumab treatment for patients with Covid-19 pneumonia - a single centre observational study Source: Virtual Congress 2021 – COVID - 19 treatments Year: 2021
Time on therapy and concomitant medication use of mepolizumab in Canada: a retrospective cohort study Source: ERJ Open Res, 7 (1) 00778-2020; 10.1183/23120541.00778-2020 Year: 2021
Does chronic assumption of inhaled/per os corticosteroids (Cs) allow osteoporosis/osteopenia (OP) and/or bone fracture (BF) in COLD patients? An epidemiological, observational and transversal survey of an over 50 yrs out-patient cohort Source: Eur Respir J 2006; 28: Suppl. 50, 62s Year: 2006
Patients‘ characteristics do not influence duration of antibiotic therapy (ABT) in hospitalized patients with community-acquired pneumonia (CAP): results from the CAPO international study Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008
Therapeutic failure among incident users of ß-lactam antibiotics: a real-world, cohort study, in primary care in Italy Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections Year: 2020
Pneumocystis pneumonia in non-HIV patients. A retrospective study (2000-2007) Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens Year: 2008
Prevalence, characteristics and management of frequently exacerbating asthma patients: an observational study in Sweden (PACEHR) Source: Eur Respir J, 52 (2) 1701927; 10.1183/13993003.01927-2017 Year: 2018
Tofacitinib versus standard of care treatment in patients with COVID-19 pneumonia and respiratory failure: a multicenter cohort study Source: Virtual Congress 2021 – Acute COVID - 19 Year: 2021
Prospective cohort study of patients complaining of high pressure with CPAP/APAP (PAP) who switch to bi-level PAP (VAuto) as second-line therapy: POP-IN study Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019
Comparison of dual vs triple therapies in patients hospitalized for COPD in France: a claims data study Source: International Congress 2018 – COPD management Year: 2018
Asthma control and COPD symptom burden: results from a multi-country observational study (SPRINT) in patients using fixed dose combination (FDC) inhalers Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018
Utility of adherence checks in patients with severe asthma eligible for biologics: a single centre retrospective analysis Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021
Community-acquired pneumonia (CAP) in patients admitted to a central hospital: an 18 months retrospective study Source: Eur Respir J 2003; 22: Suppl. 45, 150s Year: 2003
Identifying a ‘frequent exacerbator‘ phenotype in a cohort of COPD patients (EXACO study) Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease Year: 2012
Adequacy of treatment in COPD patients referred to the emergency room for disease exacerbation: an Italian multicentre observational study (the COXER study) Source: Annual Congress 2008 - Management of COPD Year: 2008
Are smokers with acute cough in primary care prescribed antibiotics more often, and to what benefit? An observational study in 13 European countries Source: Eur Respir J 2010; 35: 761-767 Year: 2010
The side effects, the outcome and the mortality of anti-tuberculosis treatment in dialyzed patients: A 10-year retrospective analysis Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015